Floatz logo

Cyclophosphamide

Vagina Tumor

HRYZ Biotech Co.Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Vagina Tumor cohort.

Asset / SponsorPhaseRating
Inno-206
Yonsei University
Phase 2CCC
Nivolumab
Instituto do Cancer do Estado de São Paulo
Phase 2CCC
Dostarlimab
Yonsei University
Phase 2CCC
Fludarabine
HRYZ Biotech Co.
Phase 1CC
Hryz-T101 Tcr-T Cell
HRYZ Biotech Co.
Phase 1CC

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →